All In Biotech

Free tool

FAERS Monitor: Cafcit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020793 or its brand name (Cafcit, Caffeine Citrate). Reports on generic versions are filed under their own applications.

Reports

2,330

Serious

2,271

97% of reports

Hospitalization

1,143

Death reported

1,231

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pemphigus1,007
  • hepatic enzyme increased974
  • glossodynia972
  • pericarditis960
  • alopecia954
  • hand deformity950
  • joint swelling944
  • anti-cyclic citrullinated peptide antibody positive931
  • rheumatoid arthritis931
  • arthropathy925
  • discomfort925
  • pain924
  • fatigue915
  • abdominal discomfort909
  • systemic lupus erythematosus909

Reports by year received

View as table
YearReports
20041
20058
200720
200861
200919
201034
201145
201247
201311
20148
20159
201610
201719
2018113
201967
2020108
2021234
2022265
2023268
2024407
2025374
2026202

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,829 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anti-cyclic citrullinated peptide antibody positiveSignal9311347.81274.91,089,505
pemphigusSignal1,007790.7752.1730,001
hand deformitySignal950704.7669.0619,008
pericarditisSignal960547.0519.9493,240
glossodyniaSignal972409.7389.8379,101
systemic lupus erythematosusSignal909237.2225.2208,479
arthropathySignal925152.7145.2137,329
discomfortSignal925138.9132.1124,986
hepatic enzyme increasedSignal974130.8124.6123,960
rheumatoid arthritisSignal93174.671.067,366
joint swellingSignal94471.167.765,078
abdominal discomfortSignal90949.246.742,964
alopeciaSignal95444.142.040,286
painSignal92413.612.911,079
fatigueSignal91510.610.18,261

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.